Berruti A - Search Results

1

Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status.

Turla A, Laganà M, Abate A, Cremaschi V, Zamparini M, Chittò M, Consoli F, Alberti A, Ambrosini R, Tamburello M, Grisanti S, Tiberio GAM, Sigala S, Cosentini D, Berruti A. Turla A, et al. Among authors: berruti a. Cancers (Basel). 2023 Sep 9;15(18):4491. doi: 10.3390/cancers15184491. Cancers (Basel). 2023. PMID: 37760461 Free PMC article.

2

Idiopathic intracranial hypertension: a possible complication in the natural history of advanced prostate cancer.

Valcamonico F, Arcangeli G, Consoli F, Nonnis D, Grisanti S, Gatti E, Berruti A, Ferrari V. Valcamonico F, et al. Among authors: berruti a. Int J Urol. 2014 Mar;21(3):335-7. doi: 10.1111/iju.12273. Epub 2013 Sep 22. Int J Urol. 2014. PMID: 24107135

3

Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.

Berruti A, Fassnacht M, Haak H, Else T, Baudin E, Sperone P, Kroiss M, Kerkhofs T, Williams AR, Ardito A, Leboulleux S, Volante M, Deutschbein T, Feelders R, Ronchi C, Grisanti S, Gelderblom H, Porpiglia F, Papotti M, Hammer GD, Allolio B, Terzolo M. Berruti A, et al. Eur Urol. 2014 Apr;65(4):832-8. doi: 10.1016/j.eururo.2013.11.006. Epub 2013 Nov 14. Eur Urol. 2014. PMID: 24268504 Free article.

4

GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity.

Fiorentini C, Bodei S, Bedussi F, Fragni M, Bonini SA, Simeone C, Zani D, Berruti A, Missale C, Memo M, Spano P, Sigala S. Fiorentini C, et al. Among authors: berruti a. Exp Cell Res. 2014 Apr 15;323(1):100-111. doi: 10.1016/j.yexcr.2014.02.025. Epub 2014 Feb 28. Exp Cell Res. 2014. PMID: 24589892 Free article.

5

Testosterone serum levels and prostate cancer prognosis: the double face of Janus.

Valcamonico F, Ferrari L, Consoli F, Amoroso V, Berruti A. Valcamonico F, et al. Among authors: berruti a. Future Oncol. 2014 May;10(7):1113-5. doi: 10.2217/fon.14.1. Future Oncol. 2014. PMID: 24947249 Free article. No abstract available.

6

Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance.

Grisanti S, Almici C, Consoli F, Buglione M, Verardi R, Bolzoni-Villaret A, Bianchetti A, Ciccarese C, Mangoni M, Ferrari L, Biti G, Marini M, Ferrari VD, Nicolai P, Magrini SM, Berruti A. Grisanti S, et al. Among authors: berruti a. PLoS One. 2014 Aug 8;9(8):e103918. doi: 10.1371/journal.pone.0103918. eCollection 2014. PLoS One. 2014. PMID: 25105871 Free PMC article.

7

Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer?

Valcamonico F, Petrelli F, Ferrari L, Ferrari V, Grisanti S, Barni S, Berruti A. Valcamonico F, et al. Among authors: berruti a. J Clin Oncol. 2014 Nov 10;32(32):3684-5. doi: 10.1200/JCO.2014.56.2017. Epub 2014 Sep 15. J Clin Oncol. 2014. PMID: 25225432 No abstract available.

8

Should adjuvant weekly paclitaxel be considered less efficacious than anthracyclines plus cyclophosphamide for lower-risk patients with early-stage breast cancer?

Amoroso V, Pedersini R, Sharratt P, Vassalli L, Ferrari L, Sigala S, Simoncini E, Berruti A. Amoroso V, et al. Among authors: berruti a. J Clin Oncol. 2015 Jan 20;33(3):290. doi: 10.1200/JCO.2014.58.7923. Epub 2014 Dec 15. J Clin Oncol. 2015. PMID: 25512451 No abstract available.

9

Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy.

Deiana L, Grisanti S, Ferrari V, Tironi A, Brugnoli G, Ferrari L, Bozzola G, Berruti A. Deiana L, et al. Among authors: berruti a. Case Rep Oncol. 2015 Mar 18;8(1):169-73. doi: 10.1159/000381209. eCollection 2015 Jan-Apr. Case Rep Oncol. 2015. PMID: 25873886 Free PMC article.

10

Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?

Generali D, Ardine M, Strina C, Milani M, Cappelletti MR, Zanotti L, Forti M, Bedussi F, Martinotti M, Amoroso V, Sigala S, Simoncini E, Berruti A, Bottini A. Generali D, et al. Among authors: berruti a. J Natl Cancer Inst Monogr. 2015 May;2015(51):32-5. doi: 10.1093/jncimonographs/lgv019. J Natl Cancer Inst Monogr. 2015. PMID: 26063883

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

521 results

Search Page